- Home
- CLDI vs NAII Comparison
CLDI vs NAII Comparison
Compare CLDI & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- NAII
- Stock Information
- Founded
- CLDI 2014
- NAII 1980
- Country
- CLDI United States
- NAII United States
- Employees
- CLDI N/A
- NAII N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- NAII Medicinal Chemicals and Botanical Products
- Sector
- CLDI Health Care
- NAII Health Care
- Exchange
- CLDI Nasdaq
- NAII Nasdaq
- Market Cap
- CLDI 22.3M
- NAII 23.7M
- IPO Year
- CLDI N/A
- NAII 1987
- Fundamental
- Price
- CLDI $0.58
- NAII $3.45
- Analyst Decision
- CLDI Strong Buy
- NAII
- Analyst Count
- CLDI 2
- NAII 0
- Target Price
- CLDI $15.00
- NAII N/A
- AVG Volume (30 Days)
- CLDI 366.6K
- NAII 10.2K
- Earning Date
- CLDI 05-13-2025
- NAII 05-13-2025
- Dividend Yield
- CLDI N/A
- NAII N/A
- EPS Growth
- CLDI N/A
- NAII N/A
- EPS
- CLDI N/A
- NAII N/A
- Revenue
- CLDI N/A
- NAII $121,853,000.00
- Revenue This Year
- CLDI N/A
- NAII N/A
- Revenue Next Year
- CLDI N/A
- NAII N/A
- P/E Ratio
- CLDI N/A
- NAII N/A
- Revenue Growth
- CLDI N/A
- NAII N/A
- 52 Week Low
- CLDI $0.53
- NAII $3.27
- 52 Week High
- CLDI $8.30
- NAII $7.26
- Technical
- Relative Strength Index (RSI)
- CLDI 33.04
- NAII 41.39
- Support Level
- CLDI $0.53
- NAII $3.43
- Resistance Level
- CLDI $0.79
- NAII $3.62
- Average True Range (ATR)
- CLDI 0.06
- NAII 0.14
- MACD
- CLDI -0.01
- NAII 0.00
- Stochastic Oscillator
- CLDI 14.57
- NAII 4.08
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.